Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2382898
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C). Patients must have already received or were not able to tolerate the standard of care, except for specific groups who have not had cancer treatment. The study will last up to approximately 4 years.
创建时间：
2021-07-15
